Status:
COMPLETED
Testosterone MD-Lotion Residual Washing Study
Lead Sponsor:
Acrux DDS Pty Ltd
Conditions:
Hypergonadism
Eligibility:
MALE
18-70 years
Phase:
PHASE1
Brief Summary
The study will evaluate the amount of Testosteron MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure.
Eligibility Criteria
Inclusion
- Healthy male subjects ≥18 and ≤ 70 years
Exclusion
- Disqualifying concurrent condition or allergy/sensitivity to Testosterone MD-Lotion
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00996151
Start Date
December 1 2009
End Date
February 1 2010
Last Update
March 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QPharm Pty Ltd
Brisbane, Queensland, Australia, 4006